Primary Site >> Pancreatic Cancer
Gene >> ABCC2
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Tissue distribution and induction of human multidrug resistant protein 3. PMID: 11850532 |
Ref: Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. PMID: 18333132 |
Ref: Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer. PMID: 19020751 |
Ref: ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. PMID: 19077464 |
Ref: Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. PMID: 20922799 |
Ref: Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line. PMID: 22907845 |
Ref: Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer. PMID: 23664167 |
Ref: The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. PMID: 25890497 |
Ref: Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. PMID: 26684804 |
Ref: Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine. PMID: 28396636 |